⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 38 in last 7 days 🍎 Food: 116 in last 7 days 🧸 Products: 98 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 38 in last 7 days 🍎 Food: 116 in last 7 days 🧸 Products: 98 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT June 8, 2026

Esomeprazol Sandoz 40 mg - magensaftresistente Tabletten 40 mg (magensaftresistente Tablette)

📷 EU Safety Watch placeholder
Esomeprazol Sandoz 40 mg - magensaftresistente Tabletten 40 mg (magensaftresistente Tablette)
📷 EU Safety Watch placeholder
Esomeprazol Sandoz 40 mg gastro-resistant tablets are unavailable in 30-tablet packs since 8 June 2026 due to manufacturing shortages; only the 14-tablet pack remains available.
⚠️
Shortage ongoing
ESOMEPRAZOL MAGNESIUM DIHYDRAT is currently in short supply in AT.
📈 Timeline
2 days active so far
June 9, 2026 June 10, 2026

What is this? Esomeprazol is a medicine that protects the stomach. It comes as a tablet you swallow.

What's happening? The 40 mg strength in 30-tablet packs is out of stock. The 14-tablet pack is still available.

Does this affect me? If you take the 40 mg dose, you may need a different pack size.

What should I do? Ask your pharmacist or doctor for advice before changing your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
ESOMEPRAZOL MAGNESIUM DIHYDRAT
Agency-published detail

ATC: A02BC05 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Sandoz GmbH, Biochemiestraße 10, 6250 Kundl, Österreich · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-06-08] · 14 Stück Schachtel, Blisterpackung [verfügbar]

First published
June 8, 2026
Last refreshed by us
1 hour ago
Severity (as classified)
Low
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Low AT 1 week ago

Esomeprazol Krka 40 mg magensaftresistente Hartkapseln (magensaftresistente Hartkapsel)

Esomeprazole Krka 40 mg gastro-resistant hard capsules are delayed in production.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Esomeprazol Sandoz 40 mg - magensaftresistente Tabletten 40 mg (magensaftresistente Tablette). Esomeprazol Sandoz 40 mg gastro-resistant tablets are unavailable in 30-tablet packs since 8 June 2026 due to manufacturing shortages; only the 14-tablet pack remains available.
▸ When was this alert issued?
This alert was issued on June 8, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Low risk. A low risk means harm is unlikely under normal use. The alert is informational but still worth reading.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.